- Home
- BOLT vs SINT Comparison
BOLT vs SINT Comparison
Compare BOLT & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- SINT
- Stock Information
- Founded
- BOLT 2015
- SINT 1996
- Country
- BOLT United States
- SINT United States
- Employees
- BOLT N/A
- SINT N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- SINT Medical/Dental Instruments
- Sector
- BOLT Health Care
- SINT Health Care
- Exchange
- BOLT Nasdaq
- SINT Nasdaq
- Market Cap
- BOLT 9.4M
- SINT 8.3M
- IPO Year
- BOLT 2021
- SINT 2014
- Fundamental
- Price
- BOLT $5.32
- SINT $4.33
- Analyst Decision
- BOLT Buy
- SINT Strong Buy
- Analyst Count
- BOLT 3
- SINT 1
- Target Price
- BOLT $47.50
- SINT $28.00
- AVG Volume (30 Days)
- BOLT 10.9K
- SINT 2.2M
- Earning Date
- BOLT 11-11-2025
- SINT 11-11-2025
- Dividend Yield
- BOLT N/A
- SINT N/A
- EPS Growth
- BOLT N/A
- SINT N/A
- EPS
- BOLT N/A
- SINT N/A
- Revenue
- BOLT $4,167,000.00
- SINT $1,861,000.00
- Revenue This Year
- BOLT N/A
- SINT N/A
- Revenue Next Year
- BOLT N/A
- SINT $87.50
- P/E Ratio
- BOLT N/A
- SINT N/A
- Revenue Growth
- BOLT N/A
- SINT N/A
- 52 Week Low
- BOLT $4.59
- SINT $1.71
- 52 Week High
- BOLT $14.36
- SINT $8.60
- Technical
- Relative Strength Index (RSI)
- BOLT 51.15
- SINT 54.92
- Support Level
- BOLT $5.00
- SINT $4.20
- Resistance Level
- BOLT $5.50
- SINT $4.73
- Average True Range (ATR)
- BOLT 0.22
- SINT 0.70
- MACD
- BOLT 0.05
- SINT -0.03
- Stochastic Oscillator
- BOLT 74.06
- SINT 25.53
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.